Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001737953-25-000004
Filing Date
2025-02-12
Accepted
2025-02-12 08:07:39
Documents
85
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q repl-20241231.htm   iXBRL 10-Q 1522854
2 EX-31.1 repl-12312024x10qxex311.htm EX-31.1 11002
3 EX-31.2 repl-12312024x10qxex312.htm EX-31.2 10737
4 EX-32.1 repl-12312024x10qxex321.htm EX-32.1 5180
5 EX-32.2 repl-12312024x10qxex322.htm EX-32.2 5191
  Complete submission text file 0001737953-25-000004.txt   7461256

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT repl-20241231.xsd EX-101.SCH 57389
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT repl-20241231_cal.xml EX-101.CAL 89271
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT repl-20241231_def.xml EX-101.DEF 204431
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT repl-20241231_lab.xml EX-101.LAB 688904
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT repl-20241231_pre.xml EX-101.PRE 467162
88 EXTRACTED XBRL INSTANCE DOCUMENT repl-20241231_htm.xml XML 935444
Mailing Address 500 UNICORN PARK WOBURN MA 01801
Business Address 500 UNICORN PARK WOBURN MA 01801 (781) 222-9600
Replimune Group, Inc. (Filer) CIK: 0001737953 (see all company filings)

EIN.: 822082553 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-38596 | Film No.: 25612087
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)